Th-17 differentiation markers for rosacea and uses thereof
US10370714B2 · kind B2 · utility
0Cited by
0References
11Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Jun 25, 2012 |
| Grant date | Aug 6, 2019 |
| Priority date | — |
| Expiry date | Apr 14, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A method is described that uses ROR gamma t, or ROR alpha to diagnose rosacea and/or to screen inhibitors of Th17 differentiation, notably in inhibiting ROR gamma t or ROR alpha. Also described is a method of using these screened inhibitors in rosacea treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.